天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡
张鑫宇 , 温绍文 , 赵斐 , 吴丽丽 , 张炅璐 , 房泽海 , 刘红杰
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (9) : 1153 -1161.
天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡
Gastrodin attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by modulating the PI3K signaling pathway and reducing reactive oxygen species levels
目的: 探讨天麻及其主要活性成分天麻素对帕金森病的潜在治疗机制,重点分析其在细胞凋亡、氧化应激及磷脂酰肌醇-3-激酶(PI3K)/RAC 丝氨酸/苏氨酸蛋白激酶(Akt)/丝氨酸/苏氨酸蛋白激酶 mTOR(mTOR)信号通路中的作用。方法: 采用 6-羟基多巴胺(6-OHDA)诱导的 PC12 细胞损伤模型,通过体外实验评估天麻素对细胞凋亡、细胞内活性氧水平及 PI3K/Akt/mTOR 信号通路相关蛋白表达的影响。结果: 实验结果表明,天麻素可显著改善 6-OHDA 诱导的 PC12 细胞凋亡,并对 PI3K 信号通路活性产生调控作用。此外,天麻素能够有效降低细胞内活性氧水平,该作用不依赖于 PI3K 信号通路的调控。结论: 天麻素可能通过降低细胞内活性氧水平并调控 PI3K/Akt/mTOR 信号通路的活性,协同发挥神经保护作用,从而减轻 6-OHDA 诱导的细胞凋亡,为其在帕金森病防治中的应用提供实验依据。
AIM: To investigate the potential therapeutic mechanisms of Gastrodia elata and its main active component gastrodin (GSD) in Parkinson's disease (PD), focusing on apoptosis, oxidative stress, and the PI3K/Akt/mTOR signaling pathway. METHODS: A 6-hydroxydopamine (6-OHDA)-induced PC12 cell damage model was used to evaluate the effects of GSD on cell apoptosis, intracellular reactive oxygen species (ROS) levels, and the expression of PI3K/Akt/mTOR signaling pathway-related proteins in vitro. RESULTS: GSD significantly attenuated 6-OHDA-induced apoptosis in PC12 cells and modulated the activity of the PI3K signaling pathway. In addition, GSD effectively reduced intracellular ROS levels, and this effect was independent of PI3K pathway regulation. CONCLUSION: Gastrodin may exert neuroprotective effects by reducing intracellular ROS levels and modulating the PI3K/Akt/mTOR signaling pathway, thereby alleviating 6-OHDA-induced apoptosis in PC12 cells. These findings provide experimental evidence supporting the potential application of GSD in PD therapy.
| [1] |
|
| [2] |
Collaborators GN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet Neurol, 2019, 18(5): 459-480. |
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
刘娟, 李彦杰, 秦合伟, |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
Zhang G, Xiong N, Zhang Z, |
| [14] |
韩欣园, 刘翼骁, 肖依彤, |
| [15] |
|
| [16] |
姬之翼, 刘鸿高, 李杰庆, |
| [17] |
中华人民共和国药典 2020 版[M].北京: 中国医药科技出版社, 2020. |
| [18] |
杨飞, 王信, 马传江, |
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
张炅璐. 天麻活性成分治疗帕金森病作用机制的网络药理学预测及实验研究[D].广州: 暨南大学, 2021. |
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
国家自然科学基金面上项目(82074306)
第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]239 号)
/
| 〈 |
|
〉 |